NEUP

Neuphoria Therapeutics
NEUP

Overview Fund Trends Analyst Outlook Journalist POV

7 hedge funds and large institutions have $935K invested in Neuphoria Therapeutics in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
7
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$397K
2
+$157K
3
+$57.6K

Top Sellers

1
-$45.7K
2
-$22.2K
3
-$10.2K
4
RhumbLine Advisers
RhumbLine Advisers
Massachusetts
-$3.98K
Name Holding Trade Value Shares
Change 		Change in
Stake
AI
1
AdvisorShares Investments
Maryland
$397K
LCM
2
Lynx1 Capital Management
Puerto Rico
$264K
PWM
3
Prosperity Wealth Management
California
$157K
MC
4
Merck & Co
New Jersey
$57.8K
CWP
5
Cyndeo Wealth Partners
Florida
$57.6K
RhumbLine Advisers
6
RhumbLine Advisers
Massachusetts
$2.39K
Morgan Stanley
7
Morgan Stanley
New York
$40
Jane Street
8
Jane Street
New York
–
Bank of America
9
Bank of America
North Carolina
–
UBS Group
10
UBS Group
Switzerland
–